Dalian BIO-CHEM Company Limited (SHA:603360)
China
· Delayed Price · Currency is CNY 20.60
+0.05 (0.24%)
Apr 29, 2026, 3:00 PM CST
Dalian BIO-CHEM Company Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,498 | 1,724 | 1,305 | 1,054 | 1,253 | 995.18 | Upgrade
|
| Other Revenue | - | - | 6.83 | 11.3 | 3.32 | 11.08 | Upgrade
|
| Revenue | 1,498 | 1,724 | 1,312 | 1,066 | 1,257 | 1,006 | Upgrade
|
| Revenue Growth (YoY) | 5.38% | 31.43% | 23.09% | -15.20% | 24.88% | 34.25% | Upgrade
|
| Cost of Revenue | 946.63 | 1,100 | 737.81 | 520.77 | 616.03 | 556.52 | Upgrade
|
| Gross Profit | 551.68 | 624.21 | 573.89 | 544.89 | 640.63 | 449.74 | Upgrade
|
| Selling, General & Admin | 165.6 | 174.62 | 111.16 | 120.52 | 132.2 | 91.52 | Upgrade
|
| Research & Development | 84.28 | 84.2 | 49.65 | 38.98 | 47.09 | 40.02 | Upgrade
|
| Other Operating Expenses | -6.08 | -3.69 | 10.92 | 10.37 | 14.93 | 9.17 | Upgrade
|
| Operating Expenses | 243.8 | 255.12 | 178.98 | 168.44 | 195.05 | 144.8 | Upgrade
|
| Operating Income | 307.88 | 369.09 | 394.91 | 376.44 | 445.58 | 304.93 | Upgrade
|
| Interest Expense | - | - | -6.7 | -3.92 | -3.72 | -11.77 | Upgrade
|
| Interest & Investment Income | - | - | 32.26 | 19.12 | 3.55 | 3.75 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 8.4 | 6.42 | 17.15 | -0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.02 | -15.04 | -17.88 | -13.69 | -0.63 | -0.89 | Upgrade
|
| EBT Excluding Unusual Items | 281.85 | 354.06 | 410.98 | 384.37 | 461.93 | 295.55 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.18 | 0.4 | - | 0.01 | -7.57 | 0.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.43 | 0.17 | - | - | 0.07 | - | Upgrade
|
| Asset Writedown | -1.13 | -1.05 | -0.26 | -0.11 | -0.26 | -0.97 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.12 | -10 | Upgrade
|
| Other Unusual Items | - | - | 3.55 | 1.5 | 7.38 | 6.87 | Upgrade
|
| Pretax Income | 281.47 | 353.57 | 414.27 | 385.78 | 461.43 | 292.04 | Upgrade
|
| Income Tax Expense | 36.64 | 46.48 | 55.45 | 57.4 | 58.87 | 41.55 | Upgrade
|
| Earnings From Continuing Operations | 244.83 | 307.09 | 358.82 | 328.38 | 402.57 | 250.49 | Upgrade
|
| Minority Interest in Earnings | -72.34 | -97.32 | -13.57 | - | - | - | Upgrade
|
| Net Income | 172.49 | 209.77 | 345.26 | 328.38 | 402.57 | 250.49 | Upgrade
|
| Net Income to Common | 172.49 | 209.77 | 345.26 | 328.38 | 402.57 | 250.49 | Upgrade
|
| Net Income Growth | -50.80% | -39.24% | 5.14% | -18.43% | 60.71% | 12.96% | Upgrade
|
| Shares Outstanding (Basic) | 686 | 699 | 711 | 697 | 692 | 687 | Upgrade
|
| Shares Outstanding (Diluted) | 686 | 699 | 711 | 697 | 692 | 694 | Upgrade
|
| Shares Change (YoY) | -1.57% | -1.63% | 2.04% | 0.64% | -0.30% | -3.01% | Upgrade
|
| EPS (Basic) | 0.25 | 0.30 | 0.49 | 0.47 | 0.58 | 0.36 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.30 | 0.49 | 0.47 | 0.58 | 0.36 | Upgrade
|
| EPS Growth | -50.01% | -38.23% | 3.03% | -18.95% | 61.20% | 16.46% | Upgrade
|
| Free Cash Flow | 538.7 | 510.03 | 88.07 | 322.33 | 345.62 | -49.58 | Upgrade
|
| Free Cash Flow Per Share | 0.79 | 0.73 | 0.12 | 0.46 | 0.50 | -0.07 | Upgrade
|
| Dividend Per Share | - | - | 0.429 | 0.306 | 0.292 | - | Upgrade
|
| Dividend Growth | - | - | 40.02% | 4.97% | - | - | Upgrade
|
| Gross Margin | 36.82% | 36.21% | 43.75% | 51.13% | 50.98% | 44.69% | Upgrade
|
| Operating Margin | 20.55% | 21.41% | 30.11% | 35.33% | 35.46% | 30.30% | Upgrade
|
| Profit Margin | 11.51% | 12.17% | 26.32% | 30.81% | 32.04% | 24.89% | Upgrade
|
| Free Cash Flow Margin | 35.95% | 29.59% | 6.71% | 30.25% | 27.50% | -4.93% | Upgrade
|
| EBITDA | 407.4 | 462.45 | 463.65 | 440.08 | 516.59 | 353.15 | Upgrade
|
| EBITDA Margin | 27.19% | 26.82% | 35.35% | 41.30% | 41.11% | 35.10% | Upgrade
|
| D&A For EBITDA | 99.52 | 93.36 | 68.73 | 63.64 | 71.01 | 48.22 | Upgrade
|
| EBIT | 307.88 | 369.09 | 394.91 | 376.44 | 445.58 | 304.93 | Upgrade
|
| EBIT Margin | 20.55% | 21.41% | 30.11% | 35.33% | 35.46% | 30.30% | Upgrade
|
| Effective Tax Rate | 13.02% | 13.15% | 13.38% | 14.88% | 12.76% | 14.23% | Upgrade
|
| Revenue as Reported | - | - | 1,312 | 1,066 | 1,257 | 1,006 | Upgrade
|
| Advertising Expenses | - | - | 0.22 | 0.65 | 0.14 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.